Communication@EMA – how are we doing?
The European Medicines Agency (EMA) has launched its bi-annual communication perception survey.
The purpose of the survey is to gather feedback from all EMA stakeholders and partners, including the general public, patients, consumers, healthcare professionals, academics, media, pharmaceutical industry and other regulators, on its external communications to the public.
The feedback will help EMA identify and address potential shortcomings and to focus on activities that meet stakeholders’ and partners’ communication needs. Key recommendations from the survey will be taken into account in EMA’s yearly communication plans.
The survey covers awareness and use of EMA communications, as well as stakeholders’ opinions on their quality and transparency. There is also an opportunity to provide additional opinions or suggestions.
EMA invites everyone to provide his or her views.
The survey will close on Wednesday, 31 May 2017. It is anonymous and should take no longer than ten minutes to complete.
EMA’s communication perception surveys are carried out by the Agency on a bi-annual basis. The first survey was run in 2015 and the results were used to establish baselines and targets against which to measure progress and improve communication activities.
The Agency will publish the results of the survey and discuss recommendations with its stakeholders.